Brandywine Global Investment Management LLC lessened its stake in Davita Inc (NYSE:DVA) by 22.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 175,943 shares of the company’s stock after selling 51,331 shares during the period. Brandywine Global Investment Management LLC owned about 0.10% of Davita worth $12,712,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Nomura Asset Management Co. Ltd. lifted its stake in shares of Davita by 8.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 24,240 shares of the company’s stock valued at $1,751,000 after purchasing an additional 1,860 shares during the period. Rock Springs Capital Management LP acquired a new position in shares of Davita in the 4th quarter valued at about $5,787,000. BlueCrest Capital Management Ltd acquired a new position in shares of Davita in the 4th quarter valued at about $2,213,000. Amundi Pioneer Asset Management Inc. acquired a new position in shares of Davita in the 4th quarter valued at about $7,290,000. Finally, AXA acquired a new position in shares of Davita in the 4th quarter valued at about $932,000. Hedge funds and other institutional investors own 85.83% of the company’s stock.
In related news, insider James K. Hilger sold 3,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $78.95, for a total transaction of $282,009.40. Following the transaction, the insider now directly owns 33,649 shares of the company’s stock, valued at approximately $2,656,588.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.
Davita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.02). Davita had a return on equity of 12.86% and a net margin of 4.65%. The firm had revenue of $2.78 billion for the quarter, compared to analyst estimates of $3.90 billion. During the same period last year, the company posted $0.98 earnings per share. analysts anticipate that Davita Inc will post 4.15 earnings per share for the current year.
DVA has been the topic of a number of recent analyst reports. TheStreet raised Davita from a “c” rating to a “b-” rating in a research note on Thursday, January 4th. Robert W. Baird reissued a “buy” rating and issued a $95.00 price objective (up from $82.00) on shares of Davita in a research note on Friday, January 12th. Bank of America reissued a “buy” rating and issued a $92.00 price objective (up from $85.00) on shares of Davita in a research note on Thursday, January 11th. Citigroup raised Davita from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $67.71 to $82.00 in a research note on Monday, December 11th. Finally, Zacks Investment Research raised Davita from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a research note on Tuesday, February 6th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, four have issued a buy rating and two have issued a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $79.30.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/13/brandywine-global-investment-management-llc-has-12-71-million-holdings-in-davita-inc-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.